ShawSpring Partners, LLC 13F holdings and portfolio analysis

Following the baseline means accepting a highly concentrated book with very little diversification beyond about 10 names. The baseline top 5 holdings are 60.07% and top 10 are 94.86%, with OKTA at 14.38%, FOUR at 13.62%, CSGP at 12.12%, BABA at 10.44%, and BRZE at 9.51%. Sector exposure is also narrow in the strategy artifact: 51.78% Information Technology, 15.59% Consumer Discretionary, 13.62% Financials, 12.12% Real Estate, and 6.9% Communication Services. Historically that exposure produced 15.41% annualized return and 9.42 alpha, but it still came with a -25.21% max drawdown. So the baseline offers strong stock-selection upside, but an investor is really buying single-name and sector leadership risk rather than broad diversification.

The recent baseline periods show a pattern of uneven but occasionally strong excess return. The best recent relative period was 2024-12-31, when optimizedReturn was 0.5% versus benchmarkReturn of -3.63%, for +4.13% excess, with turnover of 9.96 and 3 trades. Another supportive period was 2023-06-30, when the baseline gained 1.29% against -1.77% for SPY, a +3.05% excess with 4.0 turnover. The weak side is more frequent: 2025-06-30 delivered -4.23% versus +4.2% for SPY, an -8.43% excess, and 2023-09-30 lagged by -6.01% despite only 1.01 turnover. 2025-03-31 also lagged by -5.79% with 13.72 turnover. Those periods explain the trade-off well: long-run returns are strong, but concentration creates wide quarter-to-quarter dispersion around SPY.

The next check should be whether the user is comfortable with concentration and lag risk at the same time. Baseline riskNotes explicitly say the backtest used delayed filing dates, so positions may lag the manager's real-time moves. At the same time, the current book is top-heavy: top 10 concentration is 94.86%, and the latest snapshot shows new positions BABA at 10.44% and AMZN at 5.15% alongside large existing weights in OKTA, FOUR, and CSGP. Users should also inspect the worst recent periods—especially 2025-06-30 at -8.43% excess and 2023-09-30 at -6.01% excess—to judge whether this concentration is tolerable in live conditions. In practice, the decision comes down to whether you trust the manager's disclosed stock selection enough to accept reporting lag plus concentrated drawdown risk.